CIK: 0001595851 · Show all filings
Period: Q3 2023 (← Previous) (Next →)
Filing Date: Nov 14, 2023
Total Value: $304M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| XBI | SPDR SER TR | 300,000 | $21.91M | 7.2% | $73.02 | — | — | Call | 78464A870 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 330,000 | $18.81M | 6.2% | $57.00 * | $20.94 | +163.6% | CLASS A ORD | 61559X104 |
| SRPT | SAREPTA THERAPEUTICS INC | 150,000 | $18.18M | 6.0% | $121.22 * | $96.08 | +17.6% | Call | 803607100 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 250,000 | $14.25M | 4.7% | $57.00 * | $20.94 | +163.6% | Put | 61559X104 |
| — | AKERO THERAPEUTICS INC | 250,000 | $12.64M | 4.2% | $50.58 | $44.16 | — | Call | 00973Y108 |
| KRYS | KRYSTAL BIOTECH INC | 80,000 | $9.28M | 3.1% | $116.00 * | $117.03 | +4.3% | COM | 501147102 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 57,500 | $8.397M | 2.8% | $146.04 * | $197.50 | -4.7% | COM | 558868105 |
| TGTX | TG THERAPEUTICS INC | 1,000,000 | $8.36M | 2.7% | $8.36 * | $14.97 | -6.9% | COM | 88322Q108 |
| ASND | ASCENDIS PHARMA A/S | 85,000 | $7.959M | 2.6% | $93.64 | $124.74 | — | SPONSORED ADR | 04351P101 |
| AXSM | AXSOME THERAPEUTICS INC | 110,000 | $7.688M | 2.5% | $69.89 * | $36.01 | +107.6% | COM | 05464T104 |
| — | ALPINE IMMUNE SCIENCES INC | 664,132 | $7.604M | 2.5% | $11.45 | $10.07 | — | COM | 02083G100 |
| PCVX | VAXCYTE INC | 140,000 | $7.137M | 2.3% | $50.98 * | $31.83 | +55.0% | COM | 92243G108 |
| TARS | TARSUS PHARMACEUTICALS INC | 400,000 | $7.108M | 2.3% | $17.77 | $20.09 | -11.9% | COM | 87650L103 |
| APLS | APELLIS PHARMACEUTICALS INC | 185,000 | $7.037M | 2.3% | $38.04 * | $54.54 | -19.5% | Call | 03753U106 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 400,000 | $6.672M | 2.2% | $16.68 * | $17.94 | +8.2% | COM | 74366E102 |
| COGT | COGENT BIOSCIENCES INC | 650,000 | $6.338M | 2.1% | $9.75 * | $10.99 | +7.9% | COM | 19240Q201 |
| RCKT | ROCKET PHARMACEUTICALS INC | 295,000 | $6.045M | 2.0% | $20.49 * | $20.20 | -10.0% | Call | 77313F106 |
| — | AMBRX BIOPHARMA INC | 525,000 | $6.037M | 2.0% | $11.50 | $10.33 | — | SPONSORED ADS | 02290A102 |
| — | AKERO THERAPEUTICS INC | 115,000 | $5.817M | 1.9% | $50.58 | $44.16 | — | COM | 00973Y108 |
| IMVT | IMMUNOVANT INC | 130,000 | $4.991M | 1.6% | $38.39 * | $22.60 | 0.0% | COM | 45258J102 |
| SRPT | SAREPTA THERAPEUTICS INC | 40,000 | $4.849M | 1.6% | $121.22 * | $96.08 | +17.6% | COM | 803607100 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 300,000 | $4.356M | 1.4% | $14.52 * | $21.73 | -12.9% | Put | 87164F105 |
| PMVP | PMV PHARMACEUTICALS INC | 705,881 | $4.334M | 1.4% | $6.14 * | $6.22 | +10.5% | COM | 69353Y103 |
| REPL | REPLIMUNE GROUP INC | 250,000 | $4.277M | 1.4% | $17.11 * | $19.54 | +0.5% | Call | 76029N106 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 275,000 | $4.218M | 1.4% | $15.34 * | $20.10 | -5.1% | COM | 92790C104 |
| TSHA | TAYSHA GENE THERAPIES INC | 1,325,000 | $4.187M | 1.4% | $3.16 * | $1.87 | 0.0% | COM SHS | 877619106 |
| — | DECIPHERA PHARMACEUTICALS IN | 325,000 | $4.134M | 1.4% | $12.72 | $12.72 | — | COM | 24344T101 |
| PHAT | PHATHOM PHARMACEUTICALS INC | 395,000 | $4.096M | 1.3% | $10.37 * | $12.86 | +6.6% | COM | 71722W107 |
| — | REVANCE THERAPEUTICS INC | 350,000 | $4.014M | 1.3% | $11.47 | $26.11 | — | COM | 761330109 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 215,000 | $3.937M | 1.3% | $18.31 * | $27.45 | -23.0% | COM | 03237H101 |
| — | CYMABAY THERAPEUTICS INC | 237,900 | $3.547M | 1.2% | $14.91 | — | — | Call | 23257D103 |
| XENE | XENON PHARMACEUTICALS INC | 98,951 | $3.38M | 1.1% | $34.16 * | $36.94 | +1.2% | COM | 98420N105 |
| IMVT | IMMUNOVANT INC | 85,000 | $3.263M | 1.1% | $38.39 * | $22.60 | 0.0% | Put | 45258J102 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 101,443 | $3.017M | 1.0% | $29.74 * | $20.61 | 0.0% | COM | 22663K107 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 200,000 | $2.904M | 1.0% | $14.52 * | $21.73 | -12.9% | COM | 87164F105 |
| — | IMMUNOGEN INC | 175,000 | $2.777M | 0.9% | $15.87 | $9.00 | — | COM | 45253H101 |
| GPCR | STRUCTURE THERAPEUTICS INC | 55,000 | $2.773M | 0.9% | $50.42 | $50.42 | — | SPONSORED ADS | 86366E106 |
| — | AEROVATE THERAPEUTICS INC | 201,197 | $2.73M | 0.9% | $13.57 | $17.75 | — | COM | 008064107 |
| — | MORPHOSYS AG | 400,000 | $2.688M | 0.9% | $6.72 | $6.72 | — | SPONSORED ADS | 617760202 |
| CYTK | CYTOKINETICS INC | 90,000 | $2.651M | 0.9% | $29.46 * | $33.30 | 0.0% | COM NEW | 23282W605 |
| — | MIRATI THERAPEUTICS INC | 60,000 | $2.614M | 0.9% | $43.56 | $58.72 | — | COM | 60468T105 |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 325,000 | $2.597M | 0.9% | $7.99 * | $10.97 | 0.0% | COM NEW | 30233G209 |
| VKTX | VIKING THERAPEUTICS INC | 225,000 | $2.491M | 0.8% | $11.07 * | $8.44 | +69.5% | COM | 92686J106 |
| — | ASTRIA THERAPEUTICS INC | 300,000 | $2.238M | 0.7% | $7.46 | $9.04 | — | COM | 04635X102 |
| FOLD | AMICUS THERAPEUTICS INC | 175,000 | $2.128M | 0.7% | $12.16 * | $12.33 | +4.7% | COM | 03152W109 |
| — | KARUNA THERAPEUTICS INC | 12,500 | $2.114M | 0.7% | $169.09 | $144.21 | — | COM | 48576A100 |
| — | ACELYRIN INC | 200,000 | $2.034M | 0.7% | $10.17 | $10.17 | — | COM | 00445A100 |
| — | ACELYRIN INC | 200,000 | $2.034M | 0.7% | $10.17 | $10.17 | — | Put | 00445A100 |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | 100,000 | $2.006M | 0.7% | $20.06 * | $23.99 | +5.8% | COM | 98943L107 |
| BBIO | BRIDGEBIO PHARMA INC | 75,000 | $1.978M | 0.7% | $26.37 * | $19.78 | +43.4% | COM | 10806X102 |
| ACAD | ACADIA PHARMACEUTICALS INC | 80,000 | $1.667M | 0.5% | $20.84 * | $27.16 | 0.0% | COM | 004225108 |
| LEGN | LEGEND BIOTECH CORP | 22,500 | $1.511M | 0.5% | $67.17 | $67.17 | — | SPONSORED ADS | 52490G102 |
| QURE | UNIQURE NV | 215,000 | $1.443M | 0.5% | $6.71 * | $20.98 | -57.1% | SHS | N90064101 |
| RCUS | ARCUS BIOSCIENCES INC | 75,000 | $1.346M | 0.4% | $17.95 * | $19.11 | +5.1% | COM | 03969F109 |
| TVTX | TRAVERE THERAPEUTICS INC | 150,000 | $1.341M | 0.4% | $8.94 * | $14.11 | 0.0% | COM | 89422G107 |
| ARGX | ARGENX SE | 2,500 | $1.229M | 0.4% | $491.63 | $491.63 | — | SPONSORED ADR | 04016X101 |
| VTYX | VENTYX BIOSCIENCES INC | 35,000 | $1.216M | 0.4% | $34.73 | $34.57 | 0.0% | COM | 92332V107 |
| WHWK | AADI BIOSCIENCE INC | 250,000 | $1.21M | 0.4% | $4.84 * | $13.64 | -57.4% | COM | 00032Q104 |
| KALV | KALVISTA PHARMACEUTICALS INC | 100,000 | $963K | 0.3% | $9.63 * | $10.22 | 0.0% | COM | 483497103 |
| BMEA | BIOMEA FUSION INC | 65,000 | $894K | 0.3% | $13.76 * | $19.38 | -7.0% | COM | 09077A106 |
| ROIV | ROIVANT SCIENCES LTD | 64,000 | $748K | 0.2% | $11.68 * | $8.94 | +26.4% | SHS | G76279101 |
| — | VERONA PHARMA PLC | 45,000 | $734K | 0.2% | $16.30 | $21.14 | — | SPONSORED ADS | 925050106 |
| — | INHIBRX INC | 35,000 | $642K | 0.2% | $18.35 | $25.96 | — | COM | 45720L107 |
| — | FUSION PHARMACEUTICALS INC | 243,287 | $633K | 0.2% | $2.60 | $3.91 | — | COM | 36118A100 |
| ABOS | ACUMEN PHARMACEUTICALS INC | 150,000 | $623K | 0.2% | $4.15 * | $6.18 | 0.0% | COM | 00509G209 |
| — | 89BIO INC | 30,000 | $463K | 0.2% | $15.44 | $15.44 | — | COM | 282559103 |
| RNAM | AVIDITY BIOSCIENCES INC | 65,000 | $415K | 0.1% | $6.38 * | $16.33 | -47.2% | COM | 05370A108 |
| — | RAIN ONCOLOGY INC | 325,000 | $280K | 0.1% | $0.86 | $7.00 | — | COM | 75082Q105 |
| — | MERSANA THERAPEUTICS INC | 61,250 | $77,788 | 0.0% | $1.27 | $3.29 | — | COM | 59045L106 |